Adrenal Hemorrhage Follow-up

  • Author: Nicholas A Tritos, MD, DSc, MMSc, FACP, FACE; Chief Editor: George T Griffing, MD   more...
 
Updated: Jul 13, 2011
 

Further Inpatient Care

  • If acute adrenal hemorrhage is considered likely, admit the patient to the medical or surgical intensive care unit (MICU or SICU) as indicated for treatment, including glucocorticoid replacement, supportive therapy, and treatment of the underlying disease(s).
  • Admit patients for elective adrenalectomy for suspected primary adrenal tumor.
Next

Further Outpatient Care

  • Follow up to monitor adequacy and adverse effects of adrenal replacement therapy.
    • Glucocorticoid adverse effects include Cushing syndrome, linear growth retardation, and hypothalamic-pituitary axis suppression.
    • Mineralocorticoid adverse effects include edema, hypertension, hypokalemia, and alkalosis.
  • Follow-up evaluation with the short Cortrosyn stimulation test is used to assess recovery of adrenal function. This test can be performed 24 hours after the last dose of hydrocortisone or prednisone replacement.
Previous
Next

Inpatient & Outpatient Medications

  • Treatments using medications include glucocorticoid and mineralocorticoid replacement therapies. Glucocorticoid therapy should be provided routinely in the acute stage of extensive, bilateral adrenal hemorrhage without awaiting biochemical confirmation of adrenal insufficiency.
  • In the acute setting, supportive therapy with mechanical ventilation, intravenous fluid administration, and pressor therapy may be necessary to provide vital function support.
  • Specific therapy for any underlying disease(s) must be provided acutely, including antibiotics for sepsis. The use of heparin and fresh frozen plasma has been advocated in DIC cases but remains controversial.
  • Patients with chronic adrenal insufficiency must temporarily increase their glucocorticoid replacement dose (2-3 times above baseline for as long as 3-5 d) in case of minor acute illness or injury. This is known as using sick-day rules.
  • At the time of acute illness or major surgery, patients with chronic adrenal insufficiency should receive hydrocortisone (50-100 mg IV tid) with rapid tapering to maintenance, as the general condition permits.
  • In the outpatient setting, the need for continued glucocorticoid and mineralocorticoid replacement should be reassessed periodically by adrenal function testing, as previously outlined.
  • In women with adrenal insufficiency, androgen replacement therapy, including dehydroepiandrosterone (DHEA; 25-50 mg PO qd), improves libido.[15] Although available in over-the-counter preparations, DHEA has not, at the time of this writing, been approved by the Food and Drug Administration for use in women with adrenal insufficiency.
Previous
Next

Transfer

  • Transfer may be indicated for further diagnostic testing or surgery, although it is not practical in unstable patients.
Previous
Next

Deterrence/Prevention

  • Avoid volume depletion and salt restriction in the presence of chronic adrenal insufficiency, unless these are required for the treatment of coexisting conditions, such as congestive heart failure.
Previous
Next

Complications

  • Acute adrenal insufficiency (adrenal crisis) may occur only in cases of extensive, bilateral adrenal hemorrhage. The proportion of patients with bilateral adrenal hemorrhage who develop acute adrenal insufficiency is unknown and remains controversial.
  • Extensive retroperitoneal hemorrhage secondary to adrenal hemorrhage is very uncommon, although it has been reported.
  • Chronic adrenal insufficiency may occur and previously was thought to be permanent. Reports of recovery of adrenal function in patients with documented adrenal insufficiency associated with an episode of extensive, bilateral adrenal hemorrhage suggest that periodic adrenal function testing of these patients is indicated.
Previous
Next

Prognosis

  • The acute case fatality rate associated with extensive, bilateral adrenal hemorrhage is approximately 15% and varies according to the severity of underlying illness.
  • In Waterhouse-Friderichsen syndrome, the case fatality rate is 55-60%, particularly when the diagnosis is delayed. Death occurs from sepsis, despite appropriate antibiotic, glucocorticoid, and supportive treatment.
  • Recovery of adrenal function in patients with chronic adrenal insufficiency associated with adrenal hemorrhage is possible, although it appears to occur infrequently.[16]
Previous
Next

Patient Education

  • Patients with chronic adrenal insufficiency must wear an appropriate identification tag or bracelet.
  • These patients must increase (double or triple) their dose of glucocorticoid replacement with minor illness or injury, according to sick-day rules.
  • If patients with chronic adrenal insufficiency are unable to keep liquids and medications down, or if they suffer a major illness or injury, they must self-inject with hydrocortisone 100 mg intramuscularly and promptly seek medical attention.
Previous
 
Contributor Information and Disclosures
Author

Nicholas A Tritos, MD, DSc, MMSc, FACP, FACE  Assistant Professor of Medicine, Harvard Medical School; Assistant in Medicine, Neuroendocrine Unit, Massachusetts General Hospital

Nicholas A Tritos, MD, DSc, MMSc, FACP, FACE is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Physicians-American Society of Internal Medicine, American Medical Association, Endocrine Society, Massachusetts Medical Society, and Pituitary Society

Disclosure: Pfizer, Inc Salary Employment

Specialty Editor Board

Dimitris A Papanicolaou, MD  Assistant Professor, Department of Medicine/Endocrinology, Emory University

Dimitris A Papanicolaou, MD is a member of the following medical societies: American College of Physicians, Endocrine Society, and Royal Society of Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Arthur B Chausmer, MD, PhD, FACP, FACE, FACN, CNS  Professor of Medicine (Endocrinology, Adj), Johns Hopkins School of Medicine; Affiliate Research Professor, Bioinformatics and Computational Biology Program, School of Computational Sciences, George Mason University; Principal, C/A Informatics, LLC

Arthur B Chausmer, MD, PhD, FACP, FACE, FACN, CNS is a member of the following medical societies: American Association of Clinical Endocrinologists, American College of Endocrinology, American College of Nutrition, American College of Physicians, American College of Physicians-American Society of Internal Medicine, American Medical Informatics Association, American Society for Bone and Mineral Research, Endocrine Society, and International Society for Clinical Densitometry

Disclosure: Nothing to disclose.

Mark Cooper, MBBS, PhD, FRACP  Head, Diabetes & Metabolism Division, Baker Heart Research Institute, Professor of Medicine, Monash University

Disclosure: Nothing to disclose.

Chief Editor

George T Griffing, MD  Professor of Medicine, St Louis University School of Medicine

George T Griffing, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Medical Practice Executives, American College of Physician Executives, American College of Physicians, American Diabetes Association, American Federation for Medical Research, American Heart Association, Central Society for Clinical Research, Endocrine Society, International Society for Clinical Densitometry, and Southern Society for Clinical Investigation

Disclosure: Nothing to disclose.

References

  1. Rao RH. Bilateral massive adrenal hemorrhage. Med Clin North Am. 1995;79(1):107-29. [Medline].

  2. Vella A, Nippoldt TB, Morris JC 3rd. Adrenal hemorrhage: a 25-year experience at the Mayo Clinic. Mayo Clin Proc. Feb 2001;76(2):161-8. [Medline].

  3. Adem PV, Montgomery CP, Husain AN, et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med. Sep 22 2005;353(12):1245-51. [Medline]. [Full Text].

  4. Pianta M, Varma DK. Bilateral spontaneous adrenal haemorrhage complicating acute pancreatitis. Australas Radiol. Apr 2007;51(2):172-4. [Medline].

  5. Gutenberg A, Lange B, Gunawan B, et al. Spontaneous adrenal hemorrhage: a little-known complication of intracranial tumor surgery. Case report. J Neurosurg. Jun 2007;106(6):1086-8. [Medline].

  6. Rosenberger LH, Smith PW, Sawyer RG, Hanks JB, Adams RB, Hedrick TL. Bilateral adrenal hemorrhage: The unrecognized cause of hemodynamic collapse associated with heparin-induced thrombocytopenia. Crit Care Med. Apr 2011;39(4):833-8. [Medline]. [Full Text].

  7. Arnason JA, Graziano FM. Adrenal insufficiency in the antiphospholipid antibody syndrome. Semin Arthritis Rheum. Oct 1995;25(2):109-16. [Medline].

  8. Caron P, Chabannier MH, Cambus JP, et al. Definitive adrenal insufficiency due to bilateral adrenal hemorrhage and primary antiphospholipid syndrome. J Clin Endocrinol Metab. May 1998;83(5):1437-9. [Medline]. [Full Text].

  9. Vasinanukorn P, Rerknimitr R, Sriussadaporn S, et al. Adrenal hemorrhage as the first presentation of hepatocellular carcinoma. Intern Med. 2007;46(21):1779-82. [Medline]. [Full Text].

  10. Gavrilova-Jordan L, Edmister WB, Farrell MA, et al. Spontaneous adrenal hemorrhage during pregnancy: a review of the literature and a case report of successful conservative management. Obstet Gynecol Surv. Mar 2005;60(3):191-5. [Medline].

  11. Shah HR, Love L, Williamson MR, et al. Hemorrhagic adrenal metastases: CT findings. J Comput Assist Tomogr. Jan-Feb 1989;13(1):77-81. [Medline].

  12. Sinelnikov AO, Abujudeh HH, Chan D, et al. CT manifestations of adrenal trauma: experience with 73 cases. Emerg Radiol. Mar 2007;13(6):313-8. [Medline].

  13. Itoh K, Yamashita K, Satoh Y, et al. MR imaging of bilateral adrenal hemorrhage. J Comput Assist Tomogr. Nov-Dec 1988;12(6):1054-6. [Medline].

  14. Bhatia KS, Ismail MM, Sahdev A, et al. (123)I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Clin Endocrinol (Oxf). Apr 3 2008;[Medline].

  15. Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med. Sep 30 1999;341(14):1013-20. [Medline]. [Full Text].

  16. Jahangir-Hekmat M, Taylor HC, Levin H, et al. Adrenal insufficiency attributable to adrenal hemorrhage: long-term follow-up with reference to glucocorticoid and mineralocorticoid function and replacement. Endocr Pract. Jan-Feb 2004;10(1):55-61. [Medline].

  17. Dahlberg PJ, Goellner MH, Pehling GB. Adrenal insufficiency secondary to adrenal hemorrhage. Two case reports and a review of cases confirmed by computed tomography. Arch Intern Med. Apr 1990;150(4):905-9. [Medline].

  18. Duffy TP. Clinical problem-solving. The sooner the better [see comments]. N Engl J Med. Sep 2 1993;329(10):710-3. [Medline].

  19. Espinosa G, Santos E, Cervera R, et al. Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients. Medicine (Baltimore). Mar 2003;82(2):106-18. [Medline].

  20. Giraud T, Dhainaut JF, Schremmer B, et al. Adult overwhelming meningococcal purpura. A study of 35 cases, 1977-1989. Arch Intern Med. Feb 1991;151(2):310-6. [Medline].

  21. Hiroi N, Yanagisawa R, Yoshida-Hiroi M, et al. Retroperitoneal hemorrhage due to bilateral adrenal metastases from lung adenocarcinoma. J Endocrinol Invest. Jun 2006;29(6):551-4. [Medline].

  22. Korobkin M, Francis IR. Adrenal imaging. Semin Ultrasound CT MR. Aug 1995;16(4):317-30. [Medline].

  23. Kovacs KA, Lam YM, Pater JL. Bilateral massive adrenal hemorrhage. Assessment of putative risk factors by the case-control method. Medicine (Baltimore). Jan 2001;80(1):45-53. [Medline].

  24. Rao RH, Vagnucci AH, Amico JA. Bilateral massive adrenal hemorrhage: early recognition and treatment. Ann Intern Med. Feb 1 1989;110(3):227-35. [Medline].

  25. Schuchmann JA, Friedman PA. Bilateral adrenal hemorrhage: an unusual complication after bilateral total knee arthroplasty. Am J Phys Med Rehabil. Nov 2005;84(11):899-903. [Medline].

  26. Shifren JL. The role of androgens in female sexual dysfunction. Mayo Clin Proc. Apr 2004;79(4 Suppl):S19-24. [Medline].

  27. Siu SC, Kitzman DW, Sheedy PF 2nd, et al. Adrenal insufficiency from bilateral adrenal hemorrhage. Mayo Clin Proc. May 1990;65(5):664-70. [Medline].

  28. Takebayashi K, Aso Y, Tayama K, et al. Primary antiphospholipid syndrome associated with acute adrenal failure. Am J Med Sci. Jan 2003;325(1):41-4. [Medline].

  29. Varon J, Chen K, Sternbach GL. Rupert Waterhouse and Carl Friderichsen: adrenal apoplexy. J Emerg Med. Jul-Aug 1998;16(4):643-7. [Medline].

 
Previous
Next
 
Computed tomographic (CT) scans of the abdomen show normal adrenal glands several months before the onset of hemorrhage (upper panel) and enlarged adrenals 2 weeks after an acute episode of bilateral adrenal hemorrhage (lower panel). The attenuation of the adrenal glands, indicated by arrows, is increased after the acute event. Reproduced from Rao RH, Vagnucci AH, Amico JA: Bilateral massive adrenal hemorrhage: early recognition and treatment. Ann Intern Med. Feb 1 1989;110(3):227-35 with permission from the journal.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.